Mirae Asset Global Etfs Holdings Ltd. Alkermes Plc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 96,813 shares of ALKS stock, worth $3.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
96,813
Previous 102,885
5.9%
Holding current value
$3.03 Million
Previous $3.4 Million
18.49%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
395Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$910 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$578 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$314 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$257 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$200 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.13B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...